VJHemOnc is committed to improving our service to you

ASH 2019 | New data in myelodysplastic syndromes

VJHemOnc is committed to improving our service to you

Valeria Santini

Speaking from the American Society of Hematology (ASH) 2019 Annual Meeting and Exposition in Orlando, FL, Valeria Santini, MD, University of Florence, Florence, Italy, discusses the latest updates in myelodysplastic syndromes (MDS). She highlights a range of new therapeutic approaches, including rigosertib, roxadustat, and the combination of venetoclax with hypomethylating agents.

Share this video  
Similar topics

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter